Abeona Therapeutics

ABEONasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$412.645 M

$7.24 +4.93%

Close of 7 Aug 2026

Revenue

$5.82M

#3276 by revenue

Earnings

-$71.2M

Loss-making

Shares outstanding

57,049,023

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#220Atea PharmaceuticalsAVIR$420.1M
#221KamadaKMDA$419.4M
#222Abeona TherapeuticsABEO$412.6M
#223Enanta PharmaceuticalsENTA$400.4M
#224Upstream BioUPB$394.5M

Where these numbers come from

Share counts and financials for Abeona Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.